Recent Press Releases
| DATE |
TITLE (click to view) |
| May 1, 2008 | Antigenics Reports First Quarter 2008 Financial Results |
| April 24, 2008 | Antigenics To Report First Quarter 2008 Financial Results On May 1, 2008; Conference Call To Follow |
| April 9, 2008 | Antigenics to Raise $21 Million in Private Placement |
| April 8, 2008 | Oncophage® Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer |
| March 21, 2008 | Antigenics to Present Phase 3 Oncophage (vitespen) Data in Kidney Cancer at European Association of Urology Annual Congress |
| February 21, 2008 | Antigenics Reports Fourth Quarter and Year-End 2007 Financial Results and Highlights |
| February 20, 2008 | Antigenics Announces Publication of Phase 3 Melanoma Study Results in Journal of Clinical Oncology |
| February 14, 2008 | Antigenics to Report Fourth Quarter and Year-End 2007 Financial Results on February 21, 2008; Conference Call to Follow |
| January 9, 2008 | Antigenics Raises $26 Million in Private Placement |
| January 3, 2008 | Antigenics Reports Positive Data on QS-21 Stimulon® Adjuvant in Acambis’ Influenza A Vaccine |
| November 2, 2007 | Antigenics to Present at Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference |
| November 1, 2007 | Antigenics Reports Third Quarter 2007 Financial Results |
| October 25, 2007 | Data From Investigator-Sponsored Trial of Oncophage® Cancer Vaccine in Glioma Presented at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics |
| October 25, 2007 | Antigenics to Report Third Quarter 2007 Financial Results on November 1, 2007; Conference Call to Follow |
| October 10, 2007 | First Patient Registered in Investigator-Sponsored Phase 2 Trial of Antigenics’ Oncophage Cancer Vaccine in Glioma |
|
|
|
|
|
